Francois P Duhoux Selected Research

Francois P Duhoux Research Topics

Disease

27	Breast Neoplasms (Breast Cancer) 05/2024 - 01/2013
7	Neoplasms (Cancer) 01/2024 - 01/2012
6	Triple Negative Breast Neoplasms 01/2024 - 11/2018
3	Disease Progression 01/2023 - 01/2020
2	Vomiting 01/2023 - 01/2020
2	Nausea 01/2023 - 01/2020
2	Fatigue 01/2023 - 01/2020
2	Neutropenia 04/2020 - 11/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Alopecia (Baldness) 01/2023
1	Lobular Carcinoma 07/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Obesity 10/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 07/2021
1	Pain (Aches) 11/2020
1	Febrile Neutropenia 04/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Diarrhea 01/2020
1	Chronic Pain 01/2019
1	Infections 11/2018
1	Oligomenorrhea 01/2013
1	Amenorrhea 01/2013
1	Leukemia 07/2011
1	Ovarian Neoplasms (Ovarian Cancer) 01/2010
1	Ovarian Epithelial Carcinoma 01/2010

Drug/Important Bio-Agent (IBA)

4	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 11/2023
4	Hormones (Hormone)IBA 11/2023 - 01/2022
3	Ado-Trastuzumab EmtansineIBA 05/2024 - 01/2020
3	trastuzumab deruxtecanIBA 05/2024 - 01/2023
3	human ERBB2 proteinIBA 04/2024 - 01/2016
3	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 08/2022 - 09/2021
3	Phenobarbital (Luminal)FDA Link 03/2022 - 09/2021
3	KetorolacIBA 11/2020 - 10/2013
2	Epirubicin (Ellence)FDA LinkGeneric 01/2024 - 11/2018
2	durvalumabIBA 12/2023 - 11/2023
2	Proteins (Proteins, Gene)FDA Link 11/2023 - 07/2021
2	Everolimus FDA Link 03/2022 - 09/2021
2	Letrozole (Femara)FDA LinkGeneric 01/2022 - 01/2022
2	palbociclibIBA 01/2022 - 01/2022
1	Hematoxylin (Haematoxylon)IBA 05/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2023
1	Epidermal Growth Factor (EGF)IBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	Biological FactorsIBA 08/2022
1	Cadherins (E-Cadherin)IBA 07/2022
1	Gemcitabine FDA Link 01/2022
1	Thymidine KinaseIBA 01/2022
1	Radium-223IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Fulvestrant (Faslodex)FDA Link 01/2022
1	ribociclibIBA 11/2021
1	LSZ102IBA 11/2021
1	AlpelisibIBA 11/2021
1	Estrogen ReceptorsIBA 11/2021
1	AdipokinesIBA 10/2021
1	ApelinIBA 10/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2020
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 04/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	pertuzumabIBA 01/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	tucatinibIBA 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	Ketorolac Tromethamine (Acular)FDA LinkGeneric 01/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2018
1	Docetaxel (Taxotere)FDA Link 11/2018
1	ixabepilone (BMS 247550)FDA Link 11/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2018
1	Single-Domain AntibodiesIBA 01/2016
1	Estrogens (Estrogen)FDA Link 01/2013
1	Tamoxifen FDA LinkGeneric 01/2013
1	RNA Precursors (Precursor, mRNA)IBA 07/2011

Therapy/Procedure

11	Therapeutics 01/2023 - 01/2010
5	Drug Therapy (Chemotherapy) 04/2024 - 01/2013
5	Neoadjuvant Therapy 01/2024 - 12/2020
2	Adjuvant Chemotherapy 05/2023 - 12/2020
2	Precision Medicine 08/2022 - 01/2021
1	Immunotherapy 11/2023
1	Molecular Targeted Therapy 01/2023
1	Radiotherapy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 04/2020
1	Mastectomy (Mammectomy) 01/2019
1	General Anesthesia 01/2019
1	Conduction Anesthesia (Regional Anesthesia) 01/2019
1	Anesthetic Hypnosis 01/2019